We are passing along information that may be of interest to some MCC patients and families…
The Seattle MCC Support Group will host a special facilitated discussion on September 11 prior to the Nghiem Merkel Dinner Meeting. This discussion session is entitled:
“GRIEF AND GRATTITUDE”
SEPTEMBER 11th 2017: 2:00 – 5:00 PM
UW Lake Union Research Center, 750 Republican Street*, E Building, Room 130A/130B, Seattle, WA 98109
*Please note that the location on the Support Group is in another building on the UW Medical Campus (a block away from the location of the Merkel Dinner). We will have ushers and signs to guide you to this location.
Specifics of the Facilitated Discussion:
Support Group Facilitators: Judy Fihn, RN and Katie Seitz, LICSW
The Support group will be divided into two- a patient group and a caregiver group. The theme is Grief and Gratitude in honor of Gregg Schimmel who began the Seattle MCC Support Group and died in July of 2017. As was said by one of the long-term survivors of Merkel Cell said,“ I had my moments of grief, but I cannot even begin to quantify my level of gratitude today.” We are grateful to Gregg for his legacy in this work and grieve the loss of his wisdom, leadership and compassion. Participants are invited to examine their own experience of loss and gratitude.
Please visit the MCC Seattle Support Group website: https://sites.google.com/site/merkelcellcarcinomaseattle/home
The website contains helpful information about MCC and other activities of the support group.
Pre-registration is requested, though drop-ins are welcome. Please contact Krista Lachance at firstname.lastname@example.org to RSVP or for additional information.
The authoritative source on Merkel cell carcinoma.
September 22, 2020
- What is a Merkel cell?
- What is Merkel cell carcinoma?
- Symptoms & appearance of Merkel cell carcinoma
- Causes of Merkel cell carcinoma
- Surgical excision
- Mohs micrographic surgery
- Radiation therapy
- Complementary & alternative therapies
- Clinical trials
- Adjuvant Avelumab in Merkel Cell Carcinoma Trial